←
Leger-Abraham Lab21 posts
Leger-Abraham Lab avatar

Leger-Abraham Lab

@LegerAbrahamLab

Protein synthesis|Structural Biology|Parasitology

◷ Joined August 2022▧ 6 Photos and videos
Leger-Abraham Lab avatar
Leger-Abraham Lab@LegerAbrahamLab·Apr 15

We all experienced this, one way or another! But, at the end, the manuscript always gets better!!!!

0:29
World Health Organization (WHO) avatar
⟳ Leger-Abraham Lab retweeted
World Health Organization (WHO)@WHO·Jan 30

The latest Global Report on Neglected Tropical Diseases (NTDs) 2025, reveals that global official development assistance for NTDs fell by 41% between 2018 and 2023, threatening to reverse the hard-won gains. Unite. Act. Eliminate NTDs. Report bit.ly/4q4uuQg Press release bit.ly/45D1gki

Post attachment
Leger-Abraham Lab avatar
Leger-Abraham Lab@LegerAbrahamLab·13 Nov 2025

As babesiosis incidence continues to rise worldwide 🌎, our Babesia divergens ribosome structure lays the groundwork for studying newly reported rRNA modifications and identifying parasite-specific vulnerabilities for therapeutic intervention.

Leger-Abraham Lab avatar
Leger-Abraham Lab@LegerAbrahamLab·13 Nov 2025

Combining single-particle cryo-EM and nanopore sequencing enabled us to map rRNA modifications in the Babesia ribosome, including nearly half that have not been reported in any organism 😲 These novel modifications span minimized expansion segments and key functional regions.

Post attachment
Leger-Abraham Lab avatar
Leger-Abraham Lab@LegerAbrahamLab·13 Nov 2025

The Babesia ribosome structure reveals significant remodeling of the large subunit expansion segments, notably the truncation of ES7L and ES15L, coinciding with the loss of ribosomal protein eL28, which is present in P. falciparum and T. gondii.

Post attachment
Leger-Abraham Lab avatar
Leger-Abraham Lab@LegerAbrahamLab·13 Nov 2025

Babesia is a tick-borne parasite that causes mild to fatal diseases and has a broadening geographic range. To date, treatment relies on a combination of antibiotics and antimalarials, but relapsing infections are common in immunocompromised patients, and resistance is increasing.

Lucas Farnung avatar
⟳ Leger-Abraham Lab retweeted
Lucas Farnung@LucasFarnung·9 Sep 2022

The 9th New England Cryo-EM Symposium will be hosted this year at Harvard Medical School on Nov 9th, 2022. We look forward to welcoming researchers from New England and beyond to @harvardmed! More details and registration: tinyurl.com/2xtyauzx

Post attachment